ciprofibrate [orch, phsu]
Gemfibrosil [lipd, phsu]
treatment [ftcn]
Primary [qlco]
Hyperlipidaemia [dsyn]
Efficacy [qlco]
Short-term [tmco]
Safety [hcpp]
ciprofibrate [orch, phsu]
Gemfibrosil [lipd, phsu]
Compared [acty]
DOUBLE BLIND [resa]
Study [mnob]
One [qnco]
TEN [dsyn]
Primary [qlco]
Type II [clas]
Patients [podg]
To [qlco]
Receive [qlco]
ciprofibrate [orch, phsu]
mg day [qnco]
Daily [tmco]
Gemfibrosil [lipd, phsu]
mg day [qnco]
Twice daily [tmco]
Treatment Efficacy [qlco]
Measured [qlco]
Complete [qlco]
Lipid [lipd]
Lipoprotein [aapp, bacs]
Profile [lbpr]
Plasma [bdsu]
fibrinogen levels [lbpr]
TOLERABILITY [resa]
Assessed [acty]
Drug [phsu]
Compliance [qnco]
Safety [hcpp]
Evaluated [ftcn]
Laboratory [mnob, orgt]
Safety [hcpp]
Parameters [fndg]
Physical Examination [hlca]
Evaluation [ftcn]
adverse events [fndg]
Mean [qnco]
reductions [npop]
Plasma [bdsu]
TC [geoa]
Low density lipoprotein cholesterol level [lbpr]
Similar [qlco]
Two [qnco]
treatment [ftcn]
Group [idcn]
Contrast [qlco]
Mean [qnco]
Relative [famg]
reduction [npop]
Plasma [bdsu]
Triglyceride [bacs, lipd]
very low density lipoprotein triglyceride [aapp, bacs, lipd]
Level [qlco]
High [qlco]
Patients [podg]
Receive [qlco]
Gemfibrosil [lipd, phsu]
Compared [acty]
ciprofibrate [orch, phsu]
P NOS [aapp, imft]
Absolute [qlco]
reduction [npop]
Last [qlco]
Two [qnco]
Parameters [fndg]
High [qlco]
ciprofibrate [orch, phsu]
Group [idcn]
Compared [acty]
Gemfibrosil [lipd, phsu]
Group [idcn]
Mean [qnco]
Concentrations [menp]
Parameters [fndg]
Normal limits [qnco]
End [spco]
Study [mnob]
Clinical [qlco]
Relevance [qlco]
statistically significant [qnco]
Question [inpr]
ciprofibrate [orch, phsu]
therapy [ftcn]
Reduced [qlco]
Gemfibrosil [lipd, phsu]
therapy [ftcn]
Increased [qnco]
Plasma [bdsu]
fibrinogen levels [lbpr]
P NOS [aapp, imft]
Compared [acty]
baseline [bodm]
Case [ftcn]
adverse events [fndg]
Rare [tmco]
Mild [qlco]
Distributed [ftcn]
Two [qnco]
treatment [ftcn]
Group [idcn]
Laboratory [mnob, orgt]
Safety [hcpp]
Parameters [fndg]
Not [ftcn]
Show [inpr]
ciprofibrate [orch, phsu]
Gemfibrosil [lipd, phsu]
Short-term [tmco]
Efficacy [qlco]
Safety [hcpp]
Profile [lbpr]
ciprofibrate [orch, phsu]
fibrinogen levels [lbpr]
Benefit [qnco]
Once daily [tmco]
Regimen [topp]
